{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-062257","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.300148+00:00","generated_at":"2026-05-22T22:52:32.369859+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Fulgent Q1 core revenue $73.5M (+16% YoY); GAAP loss $0.37/share; reiterates FY25 guidance","bullets":["Core revenue of $73.5M, up 16% YoY; GAAP net loss of $11.5M ($0.37 loss per share).","Non-GAAP income of $1.2M ($0.04 per share); Adjusted EBITDA loss of $2.9M.","Reiterates full-year 2025 core revenue guidance of $310M.","Cash and investments $814.6M ($26.60 per share); repurchased ~516k shares for $8.7M in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-062257","json":"https://secwatch.observer/filing/0000950170-25-062257.json","markdown":"https://secwatch.observer/filing/0000950170-25-062257.md","text":"https://secwatch.observer/filing/0000950170-25-062257.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000095017025062257/0000950170-25-062257-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000095017025062257/flgt-20250502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T22:52:32.369859+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}